In recent news, biosafety has surged to the spotlight due to the unparalleled global pandemic caused by the novel coronavirus (SARS-CoV-2) and the disease it causes (COVID-19). Personal protective equipment (PPE) and respiratory protection are no longer niche – rather, they are now familiar topics to just about everyone.
There is a surge of interest in the research community surrounding the requisite safety practices for research involving specimens from SARS-CoV-2 positive individuals and COVID-19 subjects. The Centers for Disease Control and prevention (CDC), the Occupational Safety and Health Administration (OSHA), and the American Biological Safety Association International (ABSA International) provide guidelines for implementing well-established safety practices.
To learn more about conducting a risk assessment and developing a risk mitigation plan, read the full article on Advarra’s website.